The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations

References

• Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104(22), 2746–2753 (2001).
   PubMed Web of Science ®Google Scholar
• Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur. Heart J. 25(14), 1197–1207 (2004).
   PubMed Web of Science ®Google Scholar
• Fefer P, Knudtson ML, Cheema AN et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J. Am. Coll. Cardiol. 59(11), 991–997 (2012).
   PubMed Web of Science ®Google Scholar
• Badimon JJ, Ibanez B, Cimmino G. Genesis and dynamics of atherosclerotic lesions: implications for early detection. Cerebrovasc. Dis. 27(Suppl. 1), 38–47 (2009).
   PubMedGoogle Scholar
• Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc. Pathol. 13(3), 125–138 (2004).
   PubMed Web of Science ®Google Scholar
• Lowe GD. Local inflammation, endothelial dysfunction and fibrinolysis in coronary heart disease. Clin. Sci. 110(3), 327–328 (2006).
   Google Scholar
• Mallat Z, Tedgui A. Current perspective on the role of apoptosis in ­atherothrombotic disease. Circ. Res. 88(10), 998–1003 (2001).
   PubMed Web of Science ®Google Scholar
• Toschi V, Gallo R, Lettino M et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95(3), 594–599 (1997).
   PubMed Web of Science ®Google Scholar
• Hutter R, Valdiviezo C, Sauter BV et al. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation 109(16), 2001–2008 (2004).
   PubMed Web of Science ®Google Scholar
• Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann. Intern. Med. 134(3), 224–238 (2001).
   PubMed Web of Science ®Google Scholar
• Sambola A, Osende J, Hathcock J et al. Role of risk factors in the modulation of tissue factor activity and blood ­thrombogenicity. Circulation 107(7), 973–977 (2003).
   PubMed Web of Science ®Google Scholar
• Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and ­atherosclerosis in children and young adults. The Bogalusa Heart Study. N. Engl. J. Med. 338(23), 1650–1656 (1998).
   PubMed Web of Science ®Google Scholar
• Nemetz PN, Roger VL, Ransom JE, Bailey KR, Edwards WD, Leibson CL. Recent trends in the prevalence of coronary disease: a population-based autopsy study of nonnatural deaths. Arch. Intern. Med. 168(3), 264–270 (2008).
   PubMedGoogle Scholar
• Roger VL, Go AS, Lloyd-Jones DM et al.; American Heart Association Statistics Committee and Stroke Statistics ­Subcommittee. Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation 123(4), e18–e209 (2011).
   PubMed Web of Science ®Google Scholar
• Smith SC Jr. Risk-reduction therapy: the challenge to change. Presented at the 68th scientific sessions of the American Heart Association November 13, 1995 Anaheim, California. Circulation 93(12), 2205–2211 (1996).
   PubMedGoogle Scholar
• Hansson GK, Klareskog L. Pulling down the plug on atherosclerosis: cooling down the inflammasome. Nat. Med. 17(7), 790–791 (2011).
   Google Scholar
• Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 473(7347), 317–325 (2011).
   PubMed Web of Science ®Google Scholar
• Li JJ, Jiang H, Huang CX et al. Elevated level of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile. Angiology 53(3), 265–272 (2002).
   PubMedGoogle Scholar
• Libby P. Inflammation in atherosclerosis. Nature 420(6917), 868–874 (2002).
   PubMed Web of Science ®Google Scholar
• Shah PK. Mechanisms of plaque vulnerability and rupture. J. Am. Coll. Cardiol. 41(4 Suppl. S), 15S–22S (2003).
   PubMed Web of Science ®Google Scholar
• Li JJ, Fang CH, Chen MZ, Chen X, Lee SW. Activation of nuclear factor-κB and correlation with elevated plasma c-reactive protein in patients with unstable angina. Heart. Lung Circ. 13(2), 173–178 (2004).
   PubMedGoogle Scholar
• Li JJ, Wang HR, Huang CX, Xue JL, Li GS. Enhanced inflammatory response of blood monocytes to C-reactive protein in patients with unstable angina. Clin. Chim. Acta 352(1–2), 127–133 (2005).
   Google Scholar
• Shah PK. Inflammation and plaque vulnerability. Cardiovasc. Drugs Ther. 23(1), 31–40 (2009).
   PubMed Web of Science ®Google Scholar
• Michowitz Y, Arbel Y, Wexler D et al. Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int. J. Cardiol. 125(3), 347–351 (2008).
   PubMed Web of Science ®Google Scholar
• Suleiman M, Khatib R, Agmon Y et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J. Am. Coll. Cardiol. 47(5), 962–968 (2006).
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM. Inflammation and atherosclerosis: Role of c-reactive protein in risk assessment. Am. J. Med. 116 (Suppl. 6A), 9S–16S (2004).
   PubMed Web of Science ®Google Scholar
• Koenig W, Sund M, Fröhlich M et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. ­Circulation 99(2), 237–242 (1999).
   PubMed Web of Science ®Google Scholar
• Calabro P, Chang DW, Willerson JT, Yeh ET. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J. Am. Coll. Cardiol. 46(6), 1112–1113 (2005).
   PubMed Web of Science ®Google Scholar
• Calabró P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108(16), 1930–1932 (2003).
   PubMed Web of Science ®Google Scholar
• De Rosa S, Cirillo P, Pacileo M, Di Palma V, Paglia A, Chiariello M. Leptin stimulated C-reactive protein production by human coronary artery endothelial cells. J. Vasc. Res. 46(6), 609–617 (2009).
   Google Scholar
• Forte L, Cimmino G, Loffredo F et al. C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. Int. J. Cardiol. 152(1), 7–12 (2011).
   PubMedGoogle Scholar
• Cirillo P, Golino P, Calabrò P et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc. Res. 68(1), 47–55 (2005).
   PubMedGoogle Scholar
• Hattori Y, Matsumura M, Kasai K. Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc. Res. 58(1), 186–195 (2003).
   PubMed Web of Science ®Google Scholar
• Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 107(3), 398–404 (2003).
   PubMed Web of Science ®Google Scholar
• Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102(18), 2165–2168 (2000).
   PubMed Web of Science ®Google Scholar
• Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103(21), 2531–2534 (2001).
   PubMed Web of Science ®Google Scholar
• Verma S, Wang CH, Li SH et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106(8), 913–919 (2002).
   PubMed Web of Science ®Google Scholar
• Guo S, Meng S, Chen B, Liu J, Gao L, Wu Y. C-reactive protein can influence the proliferation, apoptosis, and monocyte chemotactic protein-1 production of human umbilical vein endothelial cells. DNA Cell Biol. 30(3), 157–162 (2011).
   PubMedGoogle Scholar
• Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98(11), 2572–2579 (1996).
   PubMed Web of Science ®Google Scholar
• Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82(2), 513–520 (1993).
   PubMed Web of Science ®Google Scholar
• Xie L, Chang L, Guan Y, Wang X. C-reactive protein augments interleukin-8 secretion in human peripheral blood monocytes. J. Cardiovasc. Pharmacol. 46(5), 690–696 (2005).
   PubMed Web of Science ®Google Scholar
• Galve-de Rochemonteix B, Wiktorowicz K, Kushner I, Dayer JM. C-reactive protein increases production of IL-1 α, IL-1 β, and TNF-α, and expression of mrna by human alveolar macrophages. J. Leukoc. Biol. 53, 439–445 (1993).
   PubMedGoogle Scholar
• Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90(2), 775–778 (1994).
   PubMed Web of Science ®Google Scholar
• Kaartinen M, Penttilä A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of ­atheromatous rupture. Circulation 90(4), 1669–1678 (1994).
   PubMed Web of Science ®Google Scholar
• den Dekker WK, Tempel D, Bot I et al. Mast cells induce vascular smooth muscle cell apoptosis via a toll-like receptor 4 activation pathway. Arterioscler. Thromb. Vasc. Biol. 32(8), 1960–1969 (2012).
   Google Scholar
• Doherty TM. T-cell regulation of macrophage function. Curr. Opin. Immunol. 7(3), 400–404 (1995).
   PubMed Web of Science ®Google Scholar
• Liuzzo G, Kopecky SL, Frye RL et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 100(21), 2135–2139 (1999).
   PubMed Web of Science ®Google Scholar
• Nakajima T, Goek O, Zhang X et al. De novo expression of killer ­immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ. Res. 93(2), 106–113 (2003).
   PubMed Web of Science ®Google Scholar
• Caligiuri G, Paulsson G, Nicoletti A, Maseri A, Hansson GK. Evidence for antigen-driven T-cell response in unstable angina. Circulation 102(10), 1114–1119 (2000).
   PubMed Web of Science ®Google Scholar
• De Palma R, Del Galdo F, Abbate G et al. Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation 113(5), 640–646 (2006).
   PubMedGoogle Scholar
• Ketelhuth DF, Hansson GK. Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall. Thromb. Haemost. 106(5), 779–786 (2011).
   PubMedGoogle Scholar
• Brereton CF, Sutton CE, Lalor SJ, Lavelle EC, Mills KH. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease. J. Immunol. 183(3), 1715–1723 (2009).
   PubMed Web of Science ®Google Scholar
• Chen S, Crother TR, Arditi M. Emerging role of IL-17 in atherosclerosis. J. Innate Immun. 2(4), 325–333 (2010).
   PubMed Web of Science ®Google Scholar
• Cirillo P, Golino P, Piscione F et al. Transcoronary Th-17 lymphocytes and acute coronary syndromes: new evidence from the crime scene? Int. J. Cardiol. 153(2), 215–216 (2011).
   PubMedGoogle Scholar
• Dahlbäck B. Blood coagulation. Lancet 355(9215), 1627–1632 (2000).
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM. Structure and function of von Willebrand factor. Thromb. Haemost. 82(2), 576–584 (1999).
   PubMed Web of Science ®Google Scholar
• Jackson SP. The growing complexity of platelet aggregation. Blood 109(12), 5087–5095 (2007).
   PubMed Web of Science ®Google Scholar
• Coughlin SR. How the protease thrombin talks to cells. Proc. Natl Acad. Sci. USA 96(20), 11023–11027 (1999).
   PubMed Web of Science ®Google Scholar
• Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N. Engl. J. Med. 364(18), 1746–1760 (2011).
   PubMed Web of Science ®Google Scholar
• Renné T, Pozgajová M, Grüner S et al. Defective thrombus formation in mice lacking coagulation factor XII. J. Exp. Med. 202(2), 271–281 (2005).
   PubMed Web of Science ®Google Scholar
• Rosen ED, Gailani D, Castellino FJ. FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse. Thromb. Haemost. 87(4), 774–776 (2002).
   PubMed Web of Science ®Google Scholar
• Müller F, Mutch NJ, Schenk WA et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139(6), 1143–1156 (2009).
   PubMed Web of Science ®Google Scholar
• Zito F, Lowe GD, Rumley A, McMahon AD, Humphries SE; WOSCOPS Study Group West of Scotland Coronary Prevention Study. Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study. Atherosclerosis 165(1), 153–158 (2002).
   Google Scholar
• Govers-Riemslag JW, Smid M, Cooper JA et al. The plasma kallikrein-kinin system and risk of cardiovascular disease in men. J. Thromb. Haemost. 5(9), 1896–1903 (2007).
   Google Scholar
• Siegerink B, Govers-Riemslag JW, Rosendaal FR, Ten Cate H, Algra A. Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) case-control study. Circulation 122(18), 1854–1861 (2010).
   PubMed Web of Science ®Google Scholar
• Frenette PS, Denis CV, Weiss L et al. P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J. Exp. Med. 191(8), 1413–1422 (2000).
   PubMed Web of Science ®Google Scholar
• Hrachovinová I, Cambien B, ­Hafezi-Moghadam A et al. Interaction of P-selectin and PSGL-1 generates ­microparticles that correct hemostasis in a mouse model of hemophilia A. Nat. Med. 9(8), 1020–1025 (2003).
   PubMed Web of Science ®Google Scholar
• Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol. Med. 10(4), 171–178 (2004).
   PubMed Web of Science ®Google Scholar
• Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive ­morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20(5), 1262–1275 (2000).
   PubMed Web of Science ®Google Scholar
• Cheruvu PK, Finn AV, Gardner C et al. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J. Am. Coll. Cardiol. 50(10), 940–949 (2007).
   PubMed Web of Science ®Google Scholar
• Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 82(3), 265–268 (1999).
   PubMed Web of Science ®Google Scholar
• Stone GW, Maehara A, Lansky AJ et al.; PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N. Engl. J. Med. 364(3), 226–235 (2011).
   PubMed Web of Science ®Google Scholar
• Giesen PL, Rauch U, Bohrmann B et al. Blood-borne tissue factor: another view of thrombosis. Proc. Natl Acad. Sci. USA 96(5), 2311–2315 (1999).
   PubMed Web of Science ®Google Scholar
• Bach RR. Tissue factor encryption. Arterioscler. Thromb. Vasc. Biol. 26(3), 456–461 (2006).
   PubMed Web of Science ®Google Scholar
• Rao LV, Kothari H, Pendurthi UR. Tissue factor encryption and decryption: facts and controversies. Thromb. Res. 129(Suppl. 2), S13–S17 (2012).
   PubMedGoogle Scholar
• Lechner D, Weltermann A. Circulating tissue factor-exposing microparticles. Thromb. Res. 122(Suppl. 1), S47–S54 (2008).
   PubMed Web of Science ®Google Scholar
• Chargaff E, West R. The biological significance of the thromboplastic protein of blood. J. Biol. Chem. 166(1), 189–197 (1946).
   PubMed Web of Science ®Google Scholar
• Davizon P, López JA. Microparticles and thrombotic disease. Curr. Opin. Hematol. 16(5), 334–341 (2009).
   PubMedGoogle Scholar
• Leroyer AS, Isobe H, Lesèche G et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J. Am. Coll. Cardiol. 49(7), 772–777 (2007).
   PubMed Web of Science ®Google Scholar
• Rautou PE, Leroyer AS, Ramkhelawon B et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ. Res. 108(3), 335–343 (2011).
   PubMed Web of Science ®Google Scholar
• Rauch U, Bonderman D, Bohrmann B et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 96(1), 170–175 (2000).
   PubMed Web of Science ®Google Scholar
• Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat. Med. 9(4), 458–462 (2003).
   PubMed Web of Science ®Google Scholar
• van den Berg YW, Versteeg HH. ­Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes? Hamostaseologie. 30(3), 144–149 (2010).
   PubMedGoogle Scholar
• Srinivasan R, Bogdanov VY. Splice variants of Tissue Factor and integrin-mediated signaling. Thromb. Res. 129(Suppl. 2), S34–S37 (2012).
   Google Scholar
• Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to ­inflammatory cytokines. Circ. Res. 96(12), 1233–1239 (2005).
   PubMed Web of Science ®Google Scholar
• Censarek P, Bobbe A, Grandoch M, Schrör K, Weber AA. Alternatively spliced human tissue factor (asHTF) is not pro-coagulant. Thromb. Haemost. 97(1), 11–14 (2007).
   PubMed Web of Science ®Google Scholar
• Hobbs JE, Zakarija A, Cundiff DL et al. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb. Res. 120(Suppl. 2), S13–S21 (2007).
   PubMedGoogle Scholar
• Butenas S, Orfeo T, Mann KG. Tissue factor in coagulation: Which? Where? When? Arterioscler. Thromb. Vasc. Biol. 29(12), 1989–1996 (2009).
   PubMed Web of Science ®Google Scholar
• Khorana AA, Francis CW, Menzies KE et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J. Thromb. Haemost. 6(11), 1983–1985 (2008).
   PubMed Web of Science ®Google Scholar
• Wang JG, Manly D, Kirchhofer D, Pawlinski R, Mackman N. Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J. Thromb. Haemost. 7(7), 1092–1098 (2009).
   PubMed Web of Science ®Google Scholar
• Owens AP 3rd, Passam FH, Antoniak S et al. Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J. Clin. Invest. 122(2), 558–568 (2012).
   PubMed Web of Science ®Google Scholar
• Bogdanov VY, Cimmino G, Tardos JG, Tunstead JR, Badimon JJ. Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay. J. Thromb. Haemost. 7(5), 894–897 (2009).
   PubMed Web of Science ®Google Scholar
• Cimmino G, Cirillo P, Petrillo G et al. Decreased blood-borne tissue factor activity in patients presenting with acute coronary syndrome: should the old paradigm be revisited? Circulation 122, Abstract A19396 (2010).
   Google Scholar
• Antoniak S, Rojas M, Spring D et al. Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 30(11), 2136–2142 (2010).
   Google Scholar
• Carmeliet P, Mackman N, Moons L et al. Role of tissue factor in embryonic blood vessel development. Nature 383(6595), 73–75 (1996).
   PubMed Web of Science ®Google Scholar
• Randolph GJ, Luther T, Albrecht S, Magdolen V, Muller WA. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood 92(11), 4167–4177 (1998).
   Google Scholar
• Sato Y, Asada Y, Marutsuka K, ­Hatakeyama K, Sumiyoshi A. Tissue factor induces migration of cultured aortic smooth muscle cells. Thromb. Haemost. 75(3), 389–392 (1996).
   PubMed Web of Science ®Google Scholar
• Poulsen LK, Jacobsen N, Sørensen BB et al. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J. Biol. Chem. 273(11), 6228–6232 (1998).
   PubMed Web of Science ®Google Scholar
• Pendurthi UR, Alok D, Rao LV. Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: up-regulation of poly(A) polymerase. Proc. Natl Acad. Sci. USA 94(23), 12598–12603 (1997).
   PubMedGoogle Scholar
• Taniguchi T, Kakkar AK, Tuddenham EG, Williamson RC, Lemoine NR. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer. Cancer Res. 58(19), 4461–4467 (1998).
   PubMed Web of Science ®Google Scholar
• Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J. Biol. Chem. 275(9), 6580–6585 (2000).
   PubMedGoogle Scholar
• Cirillo P, Calì G, Golino P et al. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation 109(23), 2911–2916 (2004).
   PubMedGoogle Scholar
• Golino P, Ragni M, Cirillo P et al. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat. Med. 2(1), 35–40 (1996).
   PubMed Web of Science ®Google Scholar
• Chin BS, Blann AD, Gibbs CR, Chung NA, Conway DG, Lip GY. Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure. Eur. J. Clin. Invest. 33(11), 941–948 (2003).
   PubMed Web of Science ®Google Scholar
• Moertl D, Berger R, Hammer A et al. Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure. Thromb. Haemost. 106(3), 457–465 (2011).
   PubMed Web of Science ®Google Scholar